InvestorsHub Logo
Followers 6
Posts 88
Boards Moderated 0
Alias Born 03/13/2012

Re: BooDog post# 69195

Saturday, 09/13/2014 8:43:28 PM

Saturday, September 13, 2014 8:43:28 PM

Post# of 403036
BooDog/Yooper61 - Thanks for the kind words. I try to keep my emotions in check but there is so much good info coming out of the current trials of both Kevetrin and Brilacidin. I think it was BK who also commented on the favorable response of the pancreatic cancer patient. That is one of the most treatment resistent/unfavorable response rates of all cancers. To have 4+ months of stable disease I believe is a great achievement. The potential uses for Kevetrin are endless, we will just have to wait and see how the trial results pan out but thus far the results seem to correlate to the earlier cell line and mouse/rat studies. There will be many, many future studies here for sure. I also think UOB would not be starting their combo study with Cytarabine unless they have had an opportunity to "peak under the hood" so to speak. I think there has been some informal information exchange with DF and they feel it is worth while to start now. Since it's on UOB dime, that's a big step forward.

I also can't wait to see the unblinded results of the Brilicidin trial, I think they will be all we had hoped for. Exciting times, feel like a kid waiting to come down the stairs Christmas morning.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News